Healthcare Industry News: Orthofix International
News Release - October 24, 2006
Orthofix Names New President of International DivisionHUNTERSVILLE, N.C.--(HSMN NewsFeed)--Orthofix International N.V. (NASDAQ: OFIX ) announced today that Oliver Burckhardt has joined the company as President of its International Division. As head of the company's diverse international operations, Mr. Burckhardt will lead efforts to coordinate and enhance growth opportunities in Orthofix's international markets.
Mr. Burckhardt joins Orthofix after almost eight years with Aesculap, Inc., where he held several management positions, most recently as Vice President of Spine Sales and Marketing. In that capacity he established a new U.S. business unit focused on the sales and marketing of Aesculap's spine product portfolio. As part of this process Mr. Burckhardt built a dedicated spine sales and marketing organization comprised of 60 individuals, and led the effort to add 10 new products to the spine portfolio.
While at Aesculap, Mr. Burckhardt held a leadership position on a global project team responsible for the development of a new artificial disc, and also played an integral role in a key spine acquisition. During his tenure with Aesculap he also served as Director of Global Spine Product Management, where he led the international product management team and the global product portfolio for the spine division.
Orthofix's CEO, Alan Milinazzo, stated, "after a very thorough search we are extremely pleased that Oliver has agreed to join Orthofix, where he will play a key role in developing and executing our international strategies. His international experience in the spine industry will be extremely valuable in light of our recent acquisition of Blackstone Medical. Additionally, his background in the development of global markets will enhance our prospects of unlocking significant sales opportunities for the entire Orthofix portfolio around the world."
About Orthofix International, N.V.
Orthofix International N.V., a global diversified orthopedic products company, offers a broad line of minimally invasive surgical, as well as non-surgical, products for the spine, reconstruction, and trauma market sectors that address the lifelong bone-and-joint health needs of patients of all ages, helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including Breg, Inc. and Blackstone Medical, Inc., and via partnerships with other leading orthopedic product companies, including Kendall Healthcare. In addition, Orthofix is collaborating in R&D partnerships with leading medical institutions such as the Orthopedic Research and Education Foundation, Rutgers University, the Cleveland Clinic Foundation, and National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.
This news release contains certain forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements concerning expectations associated with the development and distribution of products or markets involving Orthofix and its subsidiaries, and are based on management's current expectations and estimates and involve risks and uncertainties that could cause actual results or outcomes to differ materially from those contemplated by the forward-looking statements. Factors that could cause or contribute to such differences may include, but are not limited to, unanticipated expenditures, changing relationships with customers, suppliers and strategic partners, risks relating to the protection of intellectual property, changes to the reimbursement policies of third parties, changes to governmental regulation of medical devices, the impact of competitive products, changes to the competitive environment, the acceptance of new products in the market, conditions of the orthopedic industry and the economy and other factors described in the most recent report on Form 10-K and other periodic reports filed by Orthofix with the Securities and Exchange Commission.
Source: Orthofix International
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.